Metagenomi Therapeutics, Inc. — Cash Flow Charts
3 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-89M
Free Cash Flow
$-89M
Investing Cash Flow
$104M
Financing Cash Flow
$-356K
Capex
$574K
Stock-Based Comp
$12M
D&A
$5M
SBC Allocated Expense
$12M